Providers aren’t adopting data interoperability tools

The latest stories trending on MedCity News.

Editor's Pick

Top Story Tools for Better Data Interoperability Are Here — But Providers Aren't Adopting Them There are plenty tools and data sharing standards available to foster a more cohesive and integrated approach to healthcare interoperability. However, providers aren't really adopting these tools, experts said during a recent panel. Sponsored Content A Personalized Approach to Medication Nonadherence Presented by MedCity News & Abarca Health At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.  Learn More. Calling All BioPharma Oncology Startups Need more funding? Looking for new partnerships? This is your chance to get in front of healthcare's best industry experts and VCs. Apply to Pitch at INVEST 2024 May 21-22 in Chicago. Winners will receive a $20K branding advertising package. You don't want to miss this opportunity to share how your company is making a difference in biopharma oncology. Deadline to apply is approaching fast, Feb 29th. Apply Now

Featured News

Is Europe About to Overtake the U.S.'s Leadership Position in Healthcare Sustainability via Reprocessing? FDA's regulation of single-use device reprocessing effectively made the U.S. the leader in EP sustainability efforts early on. However, very little has been done to build on this early leadership. Zocdoc Launches Tool To Help Connect Patients to the Right Providers About 57% of patients have gone to a doctor's appointment to discover that the provider was not the right one for their condition, according to new research from Zocdoc. Because of this, the company launched a new tool called Guided Search that helps pair patients with the correct provider. Adverse Event Prompts FDA Hold on Tests of Drug in Atopic Dermatitis & Asthma The FDA clinical hold follows a a report of liver failure that may be associated with zelnecirnon, an experimental Rapt Therapeutics drug. The biotech notes that no other patient has experienced liver problems and this safety signal has not been seen in any other tests of the molecule. Sanofi, Denali Neuro Drug Fails Mid-Stage Trial in ALS; MS Study Is Continuing Sanofi, which is leading development of the Denali Therapeutics-partnered molecule, disclosed little about the clinical trial results in ALS. But this Phase 2 failure follows the 2020 clinical trial pause of a different partnered molecule that addresses the same target. Register for MedCity INVEST in Chicago Where Investors and Healthcare Startups Connect The conference, scheduled for May 21-22 at the Ritz Carlton in Chicago, is the premier boutique healthcare investment event in the U.S. Curing MedTech's Cybersecurity Contagion There is growing and coordinated momentum behind the goal of ensuring connected medical devices improve people's lives without introducing them to cybersecurity threats and associated safety risks. There also is a proven playbook for implementing the type of multi-layered, security-by-design strategies these initiatives advocate.

Resources

Slaughtering Myths, Bad Practices and Sacred Cows in Healthcare In the first episode of Debunked: Slaughtering Myths, Bad Practices and Sacred Cows in Healthcare, co-hosts Arundhati Parmar and Samir Batra discuss bad billing practices related to Arundhati's foot fracture while Samir offers solutions to the problem. They also discuss the annual J.P. Morgan Healthcare Conference, drug pricing and a healthcare transaction between General Catalyst and Summa Health. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe